Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective, Rhinorrhoea, SARS-CoV-2 test
Clinical narrative: COVID recurred/ on 17-May-2022 had COVID test was again positive; Lack of drug effect; rhinorrhea; This spontaneous case was reported by a physician and describes the occurrence of RHINORRHOEA (rhinorrhea), COVID-19 (COVID recurred/ on 17-May-2022 had COVID test was again positive) and DRUG INEFFECTIVE (Lack of drug effect) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Allergy NOS. Concomitant products included ESTRADIOL and HCTZ for an unknown indication.   On 05-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-May-2022, the patient experienced RHINORRHOEA (rhinorrhea). On an unknown date, the patient experienced COVID-19 (COVID recurred/ on 17-May-2022 had COVID test was again positive) and DRUG INEFFECTIVE (Lack of drug effect). At the time of the report, RHINORRHOEA (rhinorrhea) and DRUG INEFFECTIVE (Lack of drug effect) outcome was unknown and COVID-19 (COVID recurred/ on 17-May-2022 had COVID test was again positive) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-May-2022, SARS-CoV-2 test: negative (Negative) Negative. On 17-May-2022, SARS-CoV-2 test: positive (Positive) Positive. On an unknown date, SARS-CoV-2 test: positive (Positive) Positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient had took Pfizer from 06-May-2022 to 11-May-2022 for the COVID-19 treatment.  The COVID-19 was recurred.  On 10-May-2022, the patient was tested negative and symptoms gone.  On 17-May-2022, the patient had rhinorrhea and COVID test was again positive  Company Comment: This is a spontaneous case concerning  a  73-year-old, female patient with no relevant medical history, who experienced the unexpected non serious events of Rhinorrhoea, Covid-19, Drug ineffective. As per available statements, the events occurred 38 days after the fourth dose of mRNA-1273 COVID 19 Vaccine. It was noted on the case narrative that Test was negative on may 10 and symptoms gone. Then on May 17 had rhinorrhea and COVID test was again positive.  The benefit-risk relationship of mRNA-1273 COVID 19 Vaccine, is not affected by this report. Further information is requested.; Sender's Comments: Company Comment: This is a spontaneous case concerning  a  73-year-old, female patient with no relevant medical history, who experienced the unexpected non serious events of Rhinorrhoea, Covid-19, Drug ineffective. As per available statements, the events occurred 38 days after the fourth dose of mRNA-1273 COVID 19 Vaccine. It was noted on the case narrative that Test was negative on may 10 and symptoms gone. Then on May 17 had rhinorrhea and COVID test was again positive.  The benefit-risk relationship of mRNA-1273 COVID 19 Vaccine, is not affected by this report. Further information is requested.